Executive Summary
AstraZeneca (LON:AZN) is a pharmaceutical company, headquartered in the UK. The company produces a range of pharmaceutical products aimed at combating six main healthcare issues, including cancer, cardiovascular, respiritory and infection. AstraZeneca employs iver 67,000 people and it is active in 100 countries, including a number of emergent markets, within which revenue has increased by 12% in 2009. The company's product portfolio includes a number of high-profile products, including the cancer treatment drug Arimidex and Seroquel, which is used to treat schizophrenia and bi-polar disorder. The company earned revenue of $32,804m in 2009 and a profit before tax of $10,807m.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Astrazeneca employs around 13,000 people at 17 principal R&D centres in 8 countries. It has 29 manufacturing sites in 20 countries.
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
